Similar Articles
1061 Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
1062 Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
1063 Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
1064 Empathy assessment in healthcare students is highly heterogeneous: A systematic review and meta-analysis (2012-2016)
1065 Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
1066 Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
1067 One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation
1068 Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
1069 Sodium picosulphate or polyethylene glycol before elective colonoscopy in outpatients? A systematic review and meta-analysis
1070 Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA